Document:

EX-10.5

 Exhibit 10.5 

EMPLOYMENT AGREEMENT 
 This
EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of December 13, 2017 by and between Amendia, Inc. (the “Company”) and Paul Graveline (the “Executive”), and is effective as of
January 2, 2018 (the “Effective Date”). 
 WHEREAS, the Executive possesses certain experience and expertise that
qualify him to provide the direction and leadership required by the Company; and 
 WHEREAS, the Company desires to employ the Executive as
a senior executive of the Company and the Executive wishes to accept such employment; 
 NOW, THEREFORE, in consideration of the mutual
covenants contained herein and intending to be legally bound hereby, the Company and the Executive agree as follows: 

1.        Position and Duties. 

(a)    Effective as of the Effective Date, the Executive will be employed by the Company, on a full-time basis, as
Executive Vice President & Chief Commercial Officer of the Company and Spinal Elements, Inc. In addition, the Executive may be asked from time to time to serve as a director or officer of one or more of the Company’s Affiliates,
without further compensation. 
 (b)    The Executive agrees to perform the duties of his position and such other duties
as may reasonably be assigned to the Executive from time to time. The Executive also agrees that, while employed by the Company, he will devote his full business time and reasonable best efforts, as well as his business judgment, skill and
knowledge, exclusively to the advancement of the business interests of the Company and its Affiliates and to the discharge of his duties and responsibilities for them. Notwithstanding the foregoing, nothing in this
Section 1(b) will restrict the Executive from performing activities for or on behalf of The Graveline Family LLLP, provided that such activities do not, individually or in the aggregate, (i) interfere with the
performance of the Executive’s duties and responsibilities under this Agreement or (ii) violate this Agreement or any other agreement by and between the Executive and the Company or any of its Affiliates. 

(c)    The Executive agrees that, while employed by the Company, the Executive will comply with all Company policies,
practices and procedures and all codes of ethics or business conduct applicable to his position, as in effect from time to time. 

2.        Compensation and Benefits. During the Executive’s employment hereunder, as
compensation for all services performed by the Executive for the Company and its Affiliates and subject to the Executive’s full performance of his obligations hereunder, the Company will provide the Executive the following compensation and
benefits: 
 (a)    Base Salary. The Company will pay the Executive a base salary at the rate of $375,000 per
year, payable in accordance with the regular payroll practices of the 

 
Company and subject to adjustment from time to time by the Board of Directors (including the compensation committee thereof, the “Board”) of KAMD Holdings, Inc.
(“Parent”) in its discretion (as adjusted, from time to time, the “Base Salary”), provided that the Board shall only reduce the Base Salary in connection with an across-the-board reduction that applies to similarly-situated executives of the Company. 

(b)    Bonus Compensation. For each fiscal year completed during the Executive’s employment under this
Agreement, the Executive will be eligible to earn an annual bonus (each, an “Annual Bonus”) based on the Company’s achievement of its budgeted net sales target as established by the Board or such other performance targets as
may be mutually agreed by the Executive and the Board for such fiscal year (each such budgeted net sales target or other performance target, a “Performance Target”). The Executive’s target Annual Bonus will be 75% of the Base
Salary (the “Target Bonus”). The Company’s level of achievement of the Performance Target(s) for each fiscal year and the actual amount of any Annual Bonus will each be determined by the Board in its discretion;
provided, however, that for the Company’s 2018 fiscal year, the minimum amount of the Annual Bonus will be 50% of the Target Bonus. In order to receive any Annual Bonus hereunder, the Executive must be employed through the final
day of the fiscal year to which such Annual Bonus relates. Any Annual Bonus will be paid as soon as reasonably practicable following the completion of the Company’s audit for the applicable fiscal year, and in no event later than December 31st of the calendar year following the fiscal year to which such Annual Bonus relates. 

(c)    Participation in Employee Benefit Plans. The Executive will be eligible to participate in all employee
benefit plans of the Company from time to time in effect for employees of the Company generally, except to the extent such plans are duplicative of benefits otherwise provided to the Executive under this Agreement (e.g., a severance plan).
Notwithstanding the foregoing, the Executive’s participation in any such plans will be subject to the terms of the applicable plan documents and generally applicable Company policies, as the same may be in effect from time to time, and any
other restrictions or limitations imposed by law. 
 (d)    Vacations. The Executive will be entitled to earn
twenty (20) days of vacation per year, in addition to holidays observed by the Company. Vacation may be taken at such times and intervals as the Executive shall determine, subject to the business needs of the Company. Vacation shall otherwise
be subject to the policies of the Company, as in effect from time to time. 
 (e)    Business Expenses. The
Company will pay or reimburse the Executive for all reasonable business expenses incurred or paid by the Executive in the performance of his duties and responsibilities for the Company, subject to any maximum annual limit and other restrictions on
such expenses set by the Company and to such reasonable substantiation and documentation as may be specified from time to time. The Executive’s right to payment or reimbursement for business expenses hereunder shall be subject to the following
additional rules: (i) the amount of expenses eligible for payment or reimbursement during any calendar year shall not affect the expenses eligible for payment or reimbursement in any other calendar year, (ii) payment or reimbursement shall
be made in accordance with the Company’s policies and in any 

  
 - 2 - 

 
event not later than December 31 of the calendar year following the calendar year in which the expense or payment was incurred, and (iii) the right to payment or reimbursement shall not
be subject to liquidation or exchange for any other benefit. 
 (f)    Stock Options. As soon as reasonably
practicable following the Effective Date the Executive will receive a stock option grant to purchase 1,000,000 shares of common stock of Parent, with an exercise price equal to the fair market value of a share of common stock of Parent on the date
of the grant (the “Option”) made pursuant to Parent’s 2016 Equity Incentive Plan (the “Plan”). The terms and conditions of the Option shall be as set forth in a separate stock option award agreement (the
“Option Award”). The Option will be subject to the terms of the Plan, the Option Award, and any other applicable shareholder and/or option holder agreements and other reasonable and customary restrictions and limitations
generally applicable to equity held by Parent executives or otherwise required by law. 

3.        Confidential Information and Restricted Activities. 

(a)    Confidential Information. During the course of the Executive’s employment with the Company, the
Executive will learn of Confidential Information, and will develop Confidential Information on behalf of the Company and its Affiliates. The Executive agrees that he will not use or disclose to any Person (except as required by applicable law or for
the proper performance of his regular duties and responsibilities for the Company) any Confidential Information obtained by the Executive incident to his employment or any other association with the Company or any of its Affiliates. The Executive
agrees that this restriction will continue to apply after his employment terminates, regardless of the reason for such termination. For the avoidance of doubt, (i) nothing contained in this Agreement limits, restricts or in any other way
affects the Executive’s communicating with any governmental agency or entity, or communicating with any official or staff person of a governmental agency or entity, concerning matters relevant to such governmental agency or entity and
(ii) the Executive will not be held criminally or civilly liable under any federal or state trade secret law for disclosing a trade secret (y) in confidence to a federal, state, or local government official, either directly or indirectly,
or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or (z) in a complaint or other document filed under seal in a lawsuit or other proceeding; provided, however, that
notwithstanding this immunity from liability, the Executive may be held liable if he unlawfully accesses trade secrets by unauthorized means. 

(b)    Protection of Documents. All documents, records and files, in any media of whatever kind and description,
relating to the business, present or otherwise, of the Company or any of its Affiliates, and any copies, in whole or in part, thereof (the “Documents”), whether or not prepared by the Executive, shall be the sole and exclusive
property of the Company. The Executive agrees to safeguard all Documents and to surrender to the Company, at the time his employment terminates or at such earlier time or times as the Board or its designee may specify, all Documents then in his
possession or control. The Executive also agrees to disclose to the Company, at the time his employment terminates or at such earlier time or times as the Board or its designee may specify, all passwords necessary or desirable to obtain access to,
or that would assist in obtaining access to, any information that the Executive has password-protected on any computer equipment, network or system of the Company or any of its Affiliates. 

  
 - 3 - 

 (c)    Assignment of Rights to Intellectual Property. The
Executive shall promptly and fully disclose all Intellectual Property to the Company. The Executive hereby assigns and agrees to assign to the Company (or as otherwise directed by the Company) his full right, title and interest in and to all
Intellectual Property. The Executive agrees to execute any and all applications for domestic and foreign patents, copyrights or other proprietary rights and to do such other reasonable acts (including without limitation the execution and delivery of
instruments of further assurance or confirmation) requested by the Company to assign the Intellectual Property to the Company (or as otherwise directed by the Company) and to permit the Company to enforce any patents, copyrights or other proprietary
rights to the Intellectual Property. The Executive will not charge the Company for time spent in complying with these obligations. All copyrightable works that the Executive creates during his employment shall be considered “work made for
hire” and shall, upon creation, be owned exclusively by the Company. 
 (d)    Restricted Activities. The
Company agrees that, as of the Effective Date (and subject to the Executive’s agreement to be bound by the restrictions set forth hereunder), it will grant the Executive access to Confidential Information of the Company and its Affiliates
during the term of the Executive’s employment. In consideration of this access, the Executive’s employment with the Company, and other good and valuable consideration, the receipt and sufficiency of which the Executive hereby acknowledges,
the Executive agrees that the following restrictions on his activities during and after his employment for the time period set forth herein are reasonable and necessary to protect the legitimate interests of the Company: 

(i)    While the Executive is employed by the Company and during the twelve (12)-month period immediately following
termination of his employment, regardless of the reason therefor (in the aggregate, the “Restricted Period”), except for the benefit of the Company in connection with the Executive’s duties under this Agreement during the term
of his employment hereunder, the Executive shall not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, engage in any Restricted Business in
any geographic area in which the Company or any of its Affiliates does business or is actively planning to do business during the Executive’s employment or, with respect to the portion of the Restricted Period that follows termination of the
Executive’s employment, at the time of such termination (the “Restricted Area”) or undertake any planning for any Restricted Business within the Restricted Area. Specifically, but without limiting the foregoing, the Executive
agrees during the Restricted Period not to work or provide services, in any capacity, anywhere in the Restricted Area, whether as an employee, independent contractor or otherwise, whether with or without compensation, to any Person that is engaged
in any Restricted Business. 
 (ii)    During the Restricted Period, except for the benefit of the Company in
connection with the Executive’s duties under this Agreement during the term of his employment hereunder, the Executive will not, directly or indirectly, (a) solicit or encourage any customer, vendor, supplier, or other business partner of
the Company or any of its Affiliates, including but not limited to any physician who has directly or indirectly procured any of the Company’s or any of its Affiliates’ products, to terminate or diminish its relationship with any of them or
(b) seek to persuade any such customer, vendor, supplier, or other business partner, or 

  
 - 4 - 

 
any prospective customer, vendor, supplier, or other business partner of the Company or any of its Affiliates, including but not limited to any physician who has been solicited directly or
indirectly to procure any of the Company’s or any of its Affiliates’ products, to conduct with anyone else any business or activity which such business partner or prospective business partner (A) conducts with the Company or any of
its Affiliates or (B) could conduct with the Company or any of its Affiliates; provided, however, that these restrictions shall apply (y) only with respect to those Persons who are or have been a business partner of the
Company or any of its Affiliates at any time within the twelve (12)-month period immediately preceding the activity restricted by this Section 3(d)(ii) or whose business has been solicited on behalf of the Company or any of its Affiliates by
any of their officers, employees or agents within such twelve (12)-month period, other than by form letter, blanket mailing or published advertisement, and (z) only if the Executive has performed work for such Person during his employment with
the Company or any of its Affiliates or been introduced to, or otherwise had contact with, such Person as a result of his employment or other associations with the Company or one of its Affiliates or has had access to Confidential Information which
would assist in his solicitation of such Person. 
 (iii)    During the Restricted Period, except for the benefit of
the Company in connection with the Executive’s duties under this Agreement, the Executive will not, and will not assist any other Person to, (a) hire or engage, or solicit for hiring or engagement, any employee of the Company or any of its
Affiliates or seek to persuade any such employee to discontinue employment or (b) solicit or encourage any independent contractor providing services to the Company or any of its Affiliates to terminate or diminish its relationship with them.
For the purposes of this Agreement, an “employee” or an “independent contractor” of the Company or any of its Affiliates is any Person who was such at any time during the twenty-four (24)-month period immediately
preceding the activity restricted by this Section 3(d)(iii). 
 (e)    In signing this
Agreement, the Executive gives the Company assurance that the Executive has carefully read and considered all the terms and conditions of this Agreement, including the restraints imposed on the Executive under this
Section 3. The Executive agrees without reservation that these restraints are necessary for the reasonable and proper protection of the Company and its Affiliates, and that each and every one of the restraints is reasonable
in respect to subject matter, length of time and geographic area. The Executive further agrees that, were the Executive to breach any of the covenants contained in this Section 3, the damage to the Company and its
Affiliates would be irreparable. The Executive therefore agrees that the Company, in addition and not in the alternative to any other remedies available to it, shall be entitled to preliminary and permanent injunctive relief against any breach or
threatened breach by the Executive of any of those covenants, without having to post bond, together with an award of its reasonable attorney’s fees incurred in enforcing its rights hereunder. So that the Company may enjoy the full benefit of
the covenants contained in this Section 3, the Executive further agrees that the Restricted Period shall be tolled, and shall not run, during the period of any breach by the Executive of any of the covenants contained in
Section 3(d) hereof. The Executive and the Company further agree that, in the event that any provision of this Section 3 is determined by any court of competent jurisdiction to be unenforceable by
reason of its being extended over too great a time, too large a geographic area or too great a range of activities, that provision shall be deemed to be modified to permit its 

  
 - 5 - 

 
enforcement to the maximum extent permitted by law. It is also agreed that each of the Company’s Affiliates shall have the right to enforce all of the Executive’s obligations to that
Affiliate under this Agreement, including without limitation pursuant to this Section 3. No claimed breach of this Agreement or other violation of law attributed to the Company, or change in the nature or scope of the
Executive’s employment or other relationship with the Company or any of its Affiliates, shall operate to excuse the Executive from the performance of his obligations under this Section 3. 

4.        Termination of Employment.    The Executive’s employment
under this Agreement shall continue until terminated pursuant to this Section 4. 

(a)    By the Company For Cause. The Company may terminate the Executive’s employment for Cause upon written
notice to the Executive setting forth in reasonable detail the nature of the cause. The following, as determined by the Board in its reasonable judgment, shall constitute “Cause” for termination: (i) the Executive’s intentional
failure to perform (other than by reason of disability), or gross negligence in the performance of, the Executive’s material duties and responsibilities to the Company or any of its Affiliates hereunder; (ii) the Executive’s material
breach of this Agreement or any other material written agreement between the Executive and the Company or any of its Affiliates; or (iii) the Executive’s (A) commission of a felony or (B) theft, embezzlement or fraudulent
misconduct with results in material damage to the Company or any of its Affiliates; provided that in the case of clauses (i) and (ii) of this Section 4(a), the Executive shall, if the circumstances comprising the alleged Cause are capable
of being cured, be entitled to written notice from the Company upon the first occurrence of such circumstances comprising the alleged Cause (which notice shall include a description of the circumstances comprising the alleged Cause) and the ability
to cure such circumstances within thirty (30) days from such written notice. 
 (b)    By the Company Without
Cause. The Company may terminate the Executive’s employment at any time other than for Cause upon notice to the Executive. 

(c)    By the Executive for Good Reason. The Executive may terminate his employment for Good Reason by
(i) providing written notice to the Company specifying in reasonable detail the condition giving rise to the Good Reason no later than the thirtieth (30th) day following the date that the Executive became aware that such condition occurred;
(ii) providing the Company a period of thirty (30) days to remedy the condition so specified in the notice; and (iii) terminating his employment for Good Reason within thirty (30) days following the expiration of the period to
remedy if the Company fails to remedy the condition. The following, if occurring without the Executive’s consent, shall constitute “Good Reason” for termination: (A) a material diminution in the scope of the Executive’s
duties and authority hereunder; (B) a material breach by the Company of any provision of this Agreement; or (C) the Company requiring the Executive to relocate his primary work location as of the Effective Date by more than fifty
(50) miles (provided that required business travel on behalf of the Company or any of its Affiliates will not constitute Good Reason). 

  
 - 6 - 

 (d)    By the Executive without Good Reason. The Executive may
terminate his employment at any time without Good Reason upon sixty (60) days’ notice to the Company. The Board may elect to waive such notice period or any portion thereof. 

(e)    Death and Disability. The Executive’s employment hereunder shall automatically terminate in the event
of the Executive’s death during employment. The Company may terminate the Executive’s employment, upon notice to the Executive, in the event that the Executive becomes disabled during his employment hereunder through any illness, injury,
accident or condition of either a physical or psychological nature and, as a result, is unable to perform substantially all of the Executive’s duties and responsibilities hereunder (notwithstanding the provision of any reasonable accommodation)
for a period of any ninety (90) days during any period of three hundred sixty-five (365) consecutive days. If any question shall arise as to whether the Executive is disabled to the extent that the Executive is unable to perform
substantially all of his duties and responsibilities for the Company and its Affiliates, the Executive shall, at the Company’s request, submit to a medical examination by a physician selected by the Company to whom the Executive or his
guardian, if any, has no reasonable objection to determine whether the Executive is so disabled, and such determination shall for purposes of this Agreement be conclusive of the issue. If such a question arises and the Executive fails to submit to
the requested medical examination, the Company’s determination of the issue shall be binding on the Executive. 

5.        Other Matters Related to Termination. 

(a)    Final Compensation. In the event of termination of the Executive’s employment with the Company,
howsoever occurring, the Company shall pay the Executive (i) the Base Salary for the final payroll period of his employment, through the date his employment terminates; (ii) compensation at the rate of the Base Salary for any vacation time
earned but not used as of the date his employment terminates; (iii) any Annual Bonus for the fiscal year prior to the fiscal year during which termination occurs, solely to the extent not yet paid at the time of termination, subject to and
determined in accordance with Section 2(b); and (iv) reimbursement, in accordance with Section 2(e) hereof, for business expenses incurred by the Executive but not yet paid to the Executive as
of the date his employment terminates; provided the Executive submits all expenses and supporting documentation required within thirty (30) days of the date his employment terminates, and provided further that such expenses are reimbursable
under Company policies as then in effect (all of the foregoing, “Final Compensation”). Except as otherwise provided in Sections 5(a)(iii) and 5(a)(iv), Final Compensation will be paid to the Executive within thirty
(30) days following the date of termination (or such shorter period required by law). 
 (b)    Severance
Benefits. In the event of any termination of the Executive’s employment by the Company pursuant to Section 4(b) above or by the Executive pursuant to Section 4(c) above, (y) the
Company will pay to the Executive, in addition to Final Compensation, (i) the Base Salary over a period of twelve (12) months following the date that the Executive’s employment terminates (the “Severance Payments”)
and (ii) a pro-rated portion of any Annual Bonus for the fiscal year during which termination occurs, determined in accordance with Section 2(b) and pro-rated based on the number of days that the Executive was 

  
 - 7 - 

 
employed hereunder during such fiscal year (the “Pro-Rated Bonus”) and (z) any portion of the Option that is unvested as of the date
of termination will remain outstanding and vest in full, provided that the Option will otherwise remain subject to the terms of the Option Award and the Plan (the “Option Vesting”, and together with the Severance Payments and the Pro-Rated Bonus, the “Severance Benefits”). 
 (c)    Conditions
To And Timing Of Severance Benefits. Any obligation of the Company to provide the Executive the Severance Benefits is conditioned on the Executive’s signing and returning to the Company a timely and effective separation agreement containing
a general release of claims and other customary terms in the form provided to the Executive by the Company at the time that the Executive’s employment terminates (the “Separation Agreement”). The Separation Agreement must
become effective, if at all, by the sixtieth (60th) calendar day following the date that the Executive’s employment terminates. Any Severance Payments to which the Executive is entitled will be payable in substantially equal installments in
accordance with the normal payroll practices of the Company. The first such payment will be made on the Company’s next regular payday following the expiration of sixty (60) calendar days from the date that the Executive’s employment
terminates, but will be retroactive to the day following such date of termination. Any Pro-Rated Bonus will be paid at the later of (i) the time that bonuses for the applicable fiscal year are paid to
employees of the Company generally and (ii) the Company’s next regular payday following the expiration of sixty (60) calendar days from the date that the Executive’s employment terminates, but in no event later than December 31st
of the calendar year following the fiscal year to which the Pro-Rated Bonus relates. Any Option Vesting will become effective on the date that is sixty (60) calendar days from the date that the
Executive’s employment terminates. 
 (d)    Benefits Termination. Except for any right the Executive may
have under the federal law known as “COBRA” or other applicable law to continue participation in the Company’s group health and dental plans at his cost, the Executive’s participation in all employee benefit plans shall terminate
in accordance with the terms of the applicable benefit plans based on the date of termination of his employment, without regard to any continuation of the Base Salary or other payment to the Executive following termination of his employment, and the
Executive shall not be eligible to earn vacation or other paid time off following the termination of his employment. 

(e)    Survival. Provisions of this Agreement shall survive any termination of employment if so provided in this
Agreement or if necessary or desirable to accomplish the purposes of other surviving provisions, including without limitation the Executive’s obligations under Section 3 of this Agreement. The obligation of the Company
to provide the Severance Benefits to the Executive, and the Executive’s right to retain the same, are expressly conditioned upon the Executive’s continued full performance of his obligations under Section 3
hereof. Upon termination by either the Executive or the Company, all rights, duties and obligations of the Executive and the Company to each other shall cease, except as otherwise expressly provided in this Agreement, the Plan and the Option Award.

  
 - 8 - 

 6.        Timing of Payments and
Section 409A. 
 (a)    Notwithstanding anything to the contrary in this Agreement, if at the time
that the Executive’s employment terminates, the Executive is a “specified employee,” as defined below, any and all amounts payable under this Agreement on account of such separation from service that would (but for this provision) be
payable within six (6) months following the date of termination, shall instead be paid on the next business day following the expiration of such six (6) month period or, if earlier, upon the Executive’s death; except (i) to the
extent of amounts that do not constitute a deferral of compensation within the meaning of Treasury regulation Section 1.409A-1(b) (including without limitation by reason of the safe harbor set forth in Section 1.409A-1(b)(9)(iii), as determined by the Company in its reasonable good faith discretion); (ii) benefits which qualify as excepted welfare benefits pursuant to Treasury regulation Section 1.409A-1(a)(5); or (iii) other amounts or benefits that are not subject to the requirements of Section 409A of the Internal Revenue Code of 1986, as amended
(“Section 409A”). 
 (b)    For purposes of this Agreement, all references to
“termination of employment” and correlative phrases shall be construed to require a “separation from service” (as defined in Section 1.409A-1(h) of the Treasury regulations after
giving effect to the presumptions contained therein), and the term “specified employee” means an individual determined by the Company to be a specified employee under Treasury regulation
Section 1.409A-1(i). 
 (c)    Each payment made under this Agreement shall
be treated as a separate payment and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. 

7.        Definitions. For purposes of this Agreement, the following definitions apply: 

“Affiliates” means all persons and entities directly or indirectly controlling, controlled by or under common control with the
Company, where control may be by management authority, equity interest or otherwise. 
 “Confidential Information” means
any and all information of the Company and its Affiliates that is not generally available to the public. Confidential Information also includes any information received by the Company or any of its Affiliates from any Person with any understanding,
express or implied, that it will not be disclosed. Confidential Information does not include information (i) that enters the public domain, other than through the Executive’s breach of his obligations under this Agreement or (ii) was
in the public domain prior to its disclosure to the Executive or the Company. 
 “Intellectual Property” means inventions,
discoveries, developments, methods, processes, compositions, works, concepts and ideas (whether or not patentable or copyrightable or constituting trade secrets) conceived, made, created, developed or reduced to practice by the Executive (whether
alone or with others, whether or not during normal business hours or on or off Company premises) during the Executive’s employment with the Company (and previously with Spinal Elements, Inc.), that relate either to the business of the Company
or any of its Affiliates or to any prospective activity of the Company or any of its Affiliates or that result from 

  
 - 9 - 

 
any work performed by the Executive for the Company or any of its Affiliates or that make use of Confidential Information or any of the equipment or facilities of the Company or any of its
Affiliates. 
 “Person” means an individual, a corporation, a limited liability company, an association, a partnership, an
estate, a trust or any other entity or organization, other than the Company or any of its Affiliates. 
 “Restricted
Business” means (i) the development, manufacture, marketing and/or sale of medical implants, biologics or related products for use in spinal surgical procedures or (ii) any other spinal surgical-related business that is conducted
or in active planning to be conducted by the Company or any of its Affiliates at any time during the Executive’s employment or, with respect to the portion of the Restricted Period that follows termination of the Executive’s employment, at
the time of such termination. 
 8.    Conflicting Agreements. The Executive hereby represents and warrants that
his signing of this Agreement and the performance of his obligations under it will not breach or be in conflict with any other agreement to which the Executive is a party or is bound, and that the Executive is not now subject to any covenants
against competition or similar covenants or any court order that could affect the performance of his obligations under this Agreement. The Executive agrees that the Executive will not disclose to or use on behalf of the Company any information that
to the Executive’s knowledge is confidential or proprietary information of a third party without that party’s consent. 

9.    Withholding. All payments made by the Company under this Agreement shall be reduced by any tax or other
amounts required to be withheld by the Company to the extent required by applicable law. 
 10.    Assignment.
Neither the Executive nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; provided, however, the Company may assign its
rights and obligations under this Agreement without the Executive’s consent to one of its Affiliates or to any Person with whom the Company shall hereafter effect a reorganization, consolidate or merge, or to whom the Company shall hereafter
transfer all or substantially all of its properties or assets. This Agreement shall inure to the benefit of and be binding upon the Executive and the Company, and each of their respective successors, executors, administrators, heirs and permitted
assigns. 
 11.    Severability. If any portion or provision of this Agreement shall to any extent be declared
illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not
be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 

12.    Miscellaneous. This Agreement sets forth the entire agreement between the Executive and the Company, and
replaces all prior and contemporaneous communications, 

  
 - 10 - 

 
agreements and understandings, written or oral, with respect to the terms and conditions of the Executive’s employment, including without limitation that certain Offer Letter from Spinal
Elements, Inc. to the Executive, dated as of November 29, 2017. This Agreement may not be modified or amended, and no breach shall be deemed to be waived, unless agreed to in writing by the Executive and an expressly authorized representative
of the Board. The headings and captions in this Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement. This Agreement may be executed in two or more counterparts, each of which
shall be an original and all of which together shall constitute one and the same instrument. Counterparts delivered in .PDF by electronic mail or other electronic means shall be treated as originals for all purposes. This is a Georgia contract and
shall be governed and construed in accordance with the laws of the State of Georgia, without regard to any conflict of laws principles that would result in the application of the laws of any other jurisdiction. For the avoidance of doubt, nothing
contained herein will limit or supersede the Executive’s obligations under the Plan or the Option Award. 

13.    Notices. Any notices provided for in this Agreement shall be in writing and shall be effective when
delivered in person or deposited in the United States mail, postage prepaid, and addressed to the Executive at his last known address on the books of the Company or, in the case of the Company, to it at its principal place of business, attention of
the Chairman of the Board, or to such other address as either party may specify by notice to the other actually received. 

14.    Certain Matters of Construction. In addition to the definitions referred to or set forth below in
Section 7 hereof; (i) the words “hereof,” “herein,”, “hereunder,” and words of similar import shall refer to this Agreement as a whole and not to any particular Section or provision of
this Agreement, and reference to a particular Section of this Agreement shall include all subsections thereof; (ii) the word “including” shall mean including, without limitation; (iii) definitions in
Section 7 hereof shall be equally applicable to both nouns and verbs and the singular and plural forms of the terms defined; and (iv) the masculine, feminine and neuter genders shall each include the other. 

[Remainder of page intentionally left blank.] 

  
 - 11 - 

 IN WITNESS WHEREOF, this Agreement has been executed by the Company, by its duly authorized
representative, and by the Executive, as of the date first above written. 
  

									
	THE EXECUTIVE:	 		 		 	THE COMPANY:
					
	 /s/ Paul Graveline
	 		 		 	By:	 	 /s/ Jason Blain

	Paul Graveline	 		 		 		 	Name: Jason Blain
		 		 		 		 	Title:   President & CEO

  
 - 12 -EX-10.6

 Exhibit 10.6 

[December 17, 2018] 
 Steve Healy 

Dear Steve: 
 On behalf of KAMD Holdings, Inc.
(the “Parent”) and Spinal Elements, Inc. (the “Company”) (together with the Parent, “Spinal Elements”), I am pleased to confirm the terms of your employment with Spinal Elements, as follows: 

 

	•	 	 Title. Effective as of January 2, 2019 (the “Effective Date”), you will
continue to serve as a member of the Parent’s Board of Directors (the “Board”) and you will provide additional substantial services to the Parent by transitioning to the role of Chairman of the Board and member of the Executive
Committee of the Board (the “Executive Committee”), on the terms and conditions set forth herein. 

  

	•	 	 Role. Your duties and obligations as a member of the Board, as a member of the Executive Committee
and as Chairman of the Board shall include the customary duties, responsibilities, rights, and authority commensurate with this type of position, including fiduciary duties of loyalty and care under applicable law. You also agree that, while
employed by Spinal Elements, you will devote the majority of your working time and your best efforts, business judgment, skill and knowledge to the advancement of the business interests of the Company and its Affiliates and to the discharge of your
duties and responsibilities for them. You agree to perform the Services (as defined below) in accordance with the foregoing and such policies and procedures as may be applicable to members of the Board generally from time to time. The
“Services” shall include, without limitation: (i) attendance (telephonically, electronically or in person, as agreed) at regular and special meetings of the Board and any other committees to which you are appointed (including
monthly Executive Committee telephonic meetings); (ii) preparation and review of materials for such meetings; (iii) leading Board meetings and overseeing all Board actions and initiatives (including providing input and guidance to management on
quarterly presentations to the Board); (iv) assisting and oversight of senior management in the development and implementation of corporate strategy, growth and operating initiatives and financial plans, including annual sales, research and
development; (v) collaborating with management to develop growth and operating initiatives (including close collaboration with and mentorship of the Company’s Chief Executive Officer to manage the executive team and develop corporate
objectives, review processes, communications, and culture); (vi) assessment and oversight of senior management, organizational performance and financial performance (including without limitation frequent communications to the investment team at
Kohlberg on the performance of the Company); (vii) visible and accessible representation of the Company to its customers (including without limitation, attendance at key industry events and certain other customer telephone calls, meetings, or other
customer engagement events, as determined by the Board); (viii) development of a three-year strategic plan and narrative to prepare the Company for an initial public offering, (ix) review and assessment of companies identified for potential
acquisition by the Company, and (x) performing any other duties for the Parent or any of its Affiliates as may be designated from time to time by the Board. 

  
 1 

	•	 	 Base Compensation. Beginning on the Effective Date, you will be paid an annual salary at the rate
of $150,000 for your services as a member of the Board and as Chairman of the Board, payable in accordance with the normal payroll practices of the Company, pro-rated for any partial month of your employment
(the “Base Compensation”). 

  

	•	 	 Benefits. You will be eligible to participate in the Parent’s or the Company’s employee
benefit plans, subject to applicable law and the participation rules of the applicable plans. If applicable law or the participation rules of the Parent’s or the Company’s employee health benefit plans do not allow your participation in
such plans, the Company will pay you a stipend of up to $1,200 per month to cover the cost of health insurance coverage for you and your dependents. 

  

	•	 	 Bonus Eligibility. For each fiscal year completed during your employment under this letter
agreement, you will be eligible to earn an annual bonus (each, an “Annual Bonus”) based on the Company’s achievement of its EBITDA target for such fiscal year (each, an “EBITDA Target”), with the actual amount
of any such Annual Bonus to be determined by the Board in accordance with the bonus scale appended hereto as Exhibit A. The EBITDA Target and the Company’s level of achievement of EBITDA for each fiscal year will each be determined
by the Board in its discretion. At target level of achievement, your our Annual Bonus will be 50% of the Base Compensation (the “Target Bonus”), with an eligibility to earn a maximum Annual Bonus of 75% of the Base Compensation. In
order to receive any Annual Bonus hereunder, you must be employed through the date that such Annual Bonus is paid. For purposes of this letter agreement in determining the Annual Bonus, EBITDA shall have the same definition as in the Company’s
then current senior loan documents or, if there are no senior loan documents or if they do not contain a definition of “EBITDA,” then in the most recent senior loan documents that contain such a definition. 

 

	•	 	 Business Expenses. The Company will pay or reimburse you for all reasonable business
expenses incurred or paid by you in the performance of the Services for the Company; subject to any maximum annual limit and other restrictions on such expenses set by the Company and to such reasonable substantiation and documentation as may be
specified by the Company from time to time; provided further that any reimbursement for air travel expenses may be up to $1,000 per round-trip airline ticket. Your right to payment or reimbursement hereunder shall be subject to the following
additional rules: (i) the amount of expenses eligible for payment or reimbursement during any calendar year shall not affect the expenses eligible for payment or reimbursement in any other calendar year, (ii) payment or reimbursement shall
be made not later than December 31 of the calendar year following the calendar year in which the expense or payment was incurred and (iii) the right to payment or reimbursement shall not be subject to liquidation or exchange for any other
benefit. 

  

	•	 	 Option Award. As soon as reasonably practicable following the date hereof, you will receive a stock
option grant to purchase an additional 500,000 shares of common stock of the Parent (which, together with the previous stock option grant issued to you, will represent an option to purchase a total of 1,000,000 shares of common stock of the Parent),
with an exercise price of $1.00 per share (the “Option”) made pursuant to the Parent’s 2016 Equity 

  
 2 

	 	 
Incentive Plan (the “Plan”). The terms and conditions of the Option shall be as set forth in a separate stock option award agreement (the “Option
Award”). The Option will be subject to the terms of the Plan, the Option Award, and any other applicable shareholder and/or option holder agreements and other reasonable and customary restrictions and limitations generally applicable
to equity held by Spinal Elements executives or otherwise required by law. 

  

	•	 	 Termination of Employment. This letter agreement and your employment hereunder will end on
the earliest of: (i) your resignation from your position as Chairman of the Board and as a member of the Board; (ii) your failure to be re-appointed to the Board in accordance with the Parent’s
bylaws; or (iii) your removal from the Board, in accordance with the Parent’s bylaws. From and after the date of termination of this agreement, Spinal Elements shall have no further obligation to provide you with any compensation
whatsoever, except for the payment of any accrued but unpaid pro rata portion of the Base Compensation through the date of termination, which shall be paid within thirty (30) days of your termination or such other date as required by law.

  

	•	 	 Indemnification. You will be entitled to such indemnification rights as are contained in the
Parent’s certificate of incorporation and bylaws, as amended from time to time. 

  

	•	 	 Withholding and Status. All payments made by the Parent or the Company under this letter agreement
shall be reduced by any tax or other amounts, to the extent required to be withheld under applicable law. Your employment with Spinal Elements is at-will, and this agreement does not constitute a contract of
employment for a definite term. 

  

	•	 	 Confidential Information and Protection of Documents. You acknowledge that the Company and
its Affiliates continually develop Confidential Information, and that you may have developed and may in the future develop Confidential Information for the Company or any of its Affiliates and that you have learned and will learn in the future of
Confidential Information during the course of your employment. You agree that you will comply with all policies and procedures of the Company and its Affiliates for protecting Confidential Information, and shall never disclose to any Person (except
as required by applicable law or for the proper performance of your duties and responsibilities to the Company and its Affiliates), or use for your own benefit or gain, any Confidential Information obtained by you incident to your employment or
other association with the Company or any of its Affiliates. This restriction shall continue to apply after this letter agreement and your employment hereunder terminates, regardless of the reason for such termination. All documents, records tapes
and other media of every kind and description relating to the business, present or otherwise, of the Company or any of its Affiliates, and any copies (including without limitation electronic), in whole or in part, thereof
(“Documents”), whether or not prepared by you, shall be the sole and exclusive property of the Company and its Affiliates. You agree to safeguard all Documents and to return to the Company, at the time your employment hereunder
terminates, or at such earlier time or times as the Board or its designee may specify, all Documents and other property of the Company then in your possession or control. You also agree to disclose to the Company, at the time your employment
hereunder terminates, or at such earlier time or times as the Board or its designee may specify, all passwords necessary or desirable to obtain access to, or that would assist in obtaining access to, any information which you have password-protected
on any computer equipment, network or system of the Company or any of its Affiliates. For 

  
 3 

	 	 
the avoidance of doubt, (a) nothing contained in this letter agreement limits, restricts or in any other way affects your communicating with any governmental agency or entity, or
communicating with any official or staff person of a governmental agency or entity, concerning matters relevant to such governmental agency or entity and (b) you will not be held criminally or civilly liable under any federal or state trade
secret law for disclosing a trade secret (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law,
or (ii) in a complaint or other document filed under seal in a lawsuit or other proceeding; provided, however, that notwithstanding this immunity from liability, you may be held liable if you unlawfully access trade secrets by unauthorized
means. 

  

	•	 	 Other Covenants. In consideration of your transition to the position of Chairman of the Board and
your continued service as a member of the Board and in exchange for other good and valuable consideration hereunder, including but not limited to your receiving access to Spinal Elements’ Confidential Information, the sufficiency of which you
hereby acknowledge, you agree that some restrictions on your activities during and after your employment with Spinal Elements hereunder are necessary to protect the goodwill, Confidential Information and other legitimate interests of the Company and
its Affiliates: 

  

	 	•	 	 During your employment with the Company, and for a period of six (6) months following termination of your
employment or other engagement with the Company or any of its Affiliates, regardless of the reason therefor, you shall not, directly or indirectly, whether as owner, partner, officer, director, manager, investor, consultant, agent, employee, co-venturer or otherwise, alone or in association with any other Person, engage in any activity that directly or indirectly assists a Competing Business, in any geographic area where the Company or any of its
Affiliates conducts or is actively planning to conduct business during your service hereunder (collectively, the “Restricted Area”) or undertake any planning to engage in any activity that directly or indirectly assists a Competing
Business in the Restricted Area. 

  

	 	•	 	 During your employment with the Company, and for a period of twelve (12) months following termination of
your employment or other engagement with the Company or any of its Affiliates, regardless of the reason therefor, you shall not, directly or indirectly, hire or attempt to hire any Person who is (or within the twelve (12) months prior to such
date has been) an employee or independent contractor of the Company or any of its Affiliates, assist in such hiring by any Person, or encourage any such employee or independent contractor to terminate his, her or its relationship with the Company or
any of its Affiliates (all of the above, excluding general solicitations not specifically directed at any such Person, provided that you are not directly involved in such solicitations in any way), nor shall you solicit or encourage any Person who
is (or within the twelve (12) months prior to such date has been) a customer, vendor, supplier, or other business partner of the Company or any of its Affiliates (including but not limited to any physician who has directly or indirectly
procured any of the Company’s or any of its Affiliates’ products), or any prospective customer, vendor, supplier or other business partner of the Company or any of its Affiliates (including but not limited to any physician who has been
solicited directly 

  
 4 

	 	 
or indirectly to procure any of the Company’s or any of its Affiliates’ products) to terminate his, her or its relationship with any of them, or conduct with any such business partner
or prospective business partner any business or activity which such business partner or prospective business partner conducts could conduct with the Company or any of its Affiliates; provided, however, that the restrictions relating to business
partners and prospective business partners shall only apply if you have performed work with or for such Person during your employment hereunder or been introduced to, or otherwise had contact with, such Person as a result of your employment,
engagement or other association with the Company or one of its Affiliates or have had access to Confidential Information which would assist in your solicitation of such Person. 

 

	 	•	 	 You shall promptly and fully disclose all Intellectual Property to the Company. You hereby assign and agree to
assign to the Company (or as otherwise directed by the Company) your full right, title and interest in and to all Intellectual Property. You agree to execute any and all applications for domestic and foreign patents, copyrights or other proprietary
rights and to do such other acts (including without limitation the execution and delivery of instruments of further assurance or confirmation) requested by the Company to assign the Intellectual Property to the Company (or as otherwise directed by
the Company) and to permit the Company to enforce any patents, copyrights or other proprietary rights to the Intellectual Property. All copyrightable works that you create shall be considered “work made for hire” and shall, upon creation,
be owned exclusively by the Company. Notwithstanding the foregoing, your assignment of Intellectual Property to the Company does not apply to certain inventions (“Non-Assignable Inventions”)
as specified in Section 181.78 of the Minnesota Statutes. You acknowledge having received and reviewed notification regarding such Non-Assignable Inventions pursuant to state code, which notification is
attached hereto as Exhibit B to this Agreement. 

  

	•	 	 Enforcement. You acknowledge that you have carefully read and considered all the terms and
conditions of this letter agreement, and agree without reservation that each of the restraints contained herein is necessary for the reasonable and proper protection of the goodwill, Confidential Information and other legitimate interests of the
Company and its Affiliates; that each and every one of those restraints is reasonable in respect to subject matter, length of time and geographic area; and that these restraints, individually or in the aggregate, will not prevent you from obtaining
suitable employment or contracting opportunities during the period in which you are bound by these restraints. You further agree that you will never assert, or permit to be asserted on your behalf, in any forum, any contrary position. You further
acknowledge that, were you to breach any of the covenants contained in this letter agreement, the damages to the Company and its Affiliates would be irreparable. You therefore agree that the Company, in addition to any other remedies available to
it, shall be entitled to preliminary and permanent injunctive relief against any breach or threatened breach by you of any of said covenants, without having to post bond, and will additionally be entitled to an award of attorneys’ fees incurred
in connection with securing any relief hereunder. Further, in the event that any of the “Other Covenants” set forth in this letter agreement shall be determined by any court of competent jurisdiction to be unenforceable by reason of its
being extended over too great a time, too large a 

  
 5 

	 	 
geographic area or too great a range of activities, such provision shall be severed or deemed to be modified to permit its enforcement to the maximum extent permitted by law. You agree that,
following the termination of your employment or other engagement with the Company or any of its Affiliates, the period of restriction shall be tolled, and shall not run, during any period of time in which you are in violation of the terms of the
restrictions. It is also agreed that each of the Company’s Affiliates shall have the right to enforce all of your obligations to that Affiliate under this letter agreement, including without limitation the “Other Covenants”. No breach
of any provision of this letter agreement by the Company, or any other claimed breach of contract or violation of law, or change in the nature or scope of your relationship with the Company, shall operate to extinguish your obligation to comply with
the “Other Covenants.” 

  

	•	 	 Conflict of Interest. During your employment, you will not undertake any outside activity, whether
or not competitive with the business of the Company or any of its Affiliates, that could reasonably give rise to a conflict of interest or otherwise interfere with any of your duties or obligations to the Company or any of its Affiliates.

  

	•	 	 Definitions. 

 

	 	•	 	 “Affiliates” means, with respect to a specified party, all Persons directly or indirectly
controlling, controlled by or under common control with such specified party, where control may be by either management authority or equity interest. For the avoidance of doubt, Affiliates does not include any unrelated Kohlberg portfolio companies
that are not directly or indirectly connected with the business of the Parent. 

  

	 	•	 	 “Competing Business” means (i) the business of providing medical devices and related
products for spinal surgical procedures or (ii) any other business that the Company or any of its Affiliates conducts or is actively planning to conduct during your employment or other engagement hereunder. 

 

	 	•	 	 “Confidential Information” means any and all information of the Company and its Affiliates that
is not generally known at such time by others with whom the Company or any of its Affiliates competes or does business, or with whom any of them plan to compete or do business and any and all information, not publicly known, which, if disclosed by
the Company or any of its Affiliates would assist in competition against any of them. Confidential Information includes without limitation such information relating to (i) the development, research, testing, manufacturing, marketing and
financial activities of the Company and its Affiliates, (ii) the Products, (iii) the costs, sources of supply, financial performance and strategic plans of the Company and its Affiliates, (iv) the identity and special needs of the
customers of the Company and its Affiliates and (v) the people and organizations with whom the Company and its Affiliates have business relationships and the existence and nature of those relationships. Confidential Information also includes
comparable information that the Company or any of its Affiliates has received belonging to others or which was received by the Company or any of its Affiliates with any understanding, express or implied, that it would not be disclosed.

  

	 	•	 	 “Intellectual Property” means inventions, discoveries, developments, methods, processes,
compositions, works, concepts and ideas (whether or not patentable or 

  
 6 

	 	 
copyrightable or constituting trade secrets) (collectively, the “Inventions”) conceived, made, created, developed or reduced to practice by you (whether alone or with others,
whether or not during normal business hours or on or off Company premises) during your employment that relate to the business of the Company or any of its Affiliates or the Products or that result from any work performed by you for the Company or
any of its Affiliates or that make use of Confidential Information or any of the equipment or facilities of the Company or any of its Affiliates. Notwithstanding the foregoing, Intellectual Property shall not apply to any Invention that you develop
entirely on your own time, without using the equipment, supplies, facilities or trade secret information of the Company or any of its Affiliates, unless such Invention (a) relates to the business of the Company or any of its Affiliates or to
the actual or demonstrably anticipated research or development of the Company or any of its Affiliates or (b) results from any work performed by you for the Company or any of its Affiliates. 

 

	 	•	 	 “Person” means an individual, a corporation, an association, a partnership, an estate, a trust
and any other entity or organization, other than the Parent or any of its Affiliates. 

  

	 	•	 	 “Products” means all products planned, researched, developed, tested, manufactured, sold,
licensed, leased or otherwise distributed or put into use by the Company or any of its Affiliates, together with all services provided or planned by the Company or any of its Affiliates, during your employment or other engagement with the Company or
any of its Affiliates. 

  

	•	 	 Miscellaneous. The Parent and the Company shall each be joint and severally liable for any
payment obligation under this letter agreement. This agreement may not be modified or amended, and no breach shall be deemed to be waived, unless agreed to in writing by you and the Parent. If any portion of this letter agreement shall to any extent
be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this letter agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or
unenforceable, shall not be affected thereby, and each portion or provision of this letter agreement shall be valid and enforceable to the fullest extent permitted by law. This is a Delaware agreement and shall be construed and enforced under and be
governed in all respects by the laws of Delaware without regard to any conflict of law principles that would result in the application of the laws of any other jurisdiction. This letter sets forth the entire agreement between you and Spinal
Elements, and replaces all prior and contemporaneous communications, agreements and understandings, written or oral, with respect to the terms and conditions of your employment with or other services to Spinal Elements, including without limitation
the letter agreement between you and Spinal Elements dated as of May 7, 2018 (the “Prior Agreement”). Notwithstanding the foregoing, this letter will not supersede any effective assignment of intellectual property to Spinal
Elements pursuant to the Prior Agreement. 

 [Signature page immediately follows.] 

  
 7 

 If you are in agreement with the contents of this letter, please execute both copies in the
space provided below and return one copy to me, retaining the other copy for your records. If you have any questions, please do not hesitate to contact me. 
  

	
	Sincerely,
	
	Spinal Elements, Inc.
	
	 /s/ Jason Blain

	Jason Blain
	Chief Executive Officer
	
	KAMD Holdings, Inc.
	
	 /s/ Chris Anderson Chris Anderson

	 Chris Anderson
 Vice President

	
	 /s/ Shant Mardirossian

	Shant Mardirossian
	Partner and Chief Operating Officer, Kohlberg & Co.

 Accepted and agreed: 
  

							
	 /s/ Steve Healy

Steve Healy
	 		 	 12-17-18

Date
	  	

  
 8 

 EXHIBIT A 

BONUS SCALE 
  

					
	 EBITDA Results/

EBITDA Target
	  	 Percentage of

Target Bonus Payable

			
	No Less Than	 	Less Than	  	 
	 90%
	 	91%	  	10%
	 91%
	 	92%	  	20%
	 92%
	 	93%	  	30%
	 93%
	 	94%	  	40%
	 94%
	 	95%	  	50%
	 95%
	 	96%	  	60%
	 96%
	 	97%	  	70%
	 97%
	 	98%	  	80%
	 98%
	 	99%	  	90%
	 99%
	 	100%	  	100%
	 100%
	 	101%	  	102%
	 101%
	 	102%	  	104%
	 102%
	 	103%	  	106%
	 103%
	 	104%	  	108%
	 104%
	 	105%	  	110%
	 105%
	 	106%	  	112%
	 106%
	 	107%	  	114%
	 107%
	 	108%	  	116%
	 108%
	 	109%	  	118%
	 109%
	 	110%	  	120%
	 110%
	 	111%	  	123%
	 111%
	 	112%	  	126%
	 112%
	 	113%	  	129%
	 113%
	 	114%	  	132%
	 114%
	 	115%	  	135%
	 115%
	 	116%	  	138%
	 116%
	 	117%	  	141%
	 117%
	 	118%	  	144%
	 118%
	 	119%	  	147%
	 119%
	 	120%	  	150%

  
 9 

 EXHIBIT B 

INVENTION ASSIGNMENT NOTICE 

You are hereby notified that the Employment Agreement between you and KAMD Holdings, Inc. and Spinal Elements, Inc. dated as of [December
    , 2018], does not apply to any invention which qualifies fully for exclusion under the provisions of Section 181.78 of the Minnesota Statutes. Following is the text of Section 181.78 of the Minnesota
Statutes: 
 MINNESOTA STATUTES SECTION 181.78 

181.78 AGREEMENTS; TERMS RELATING TO INVENTIONS. 

Subdivision 1.Inventions not related to employment. 

Any provision in an employment agreement which provides that an employee shall assign or offer to assign any of the employee’s rights in
an invention to the employer shall not apply to an invention for which no equipment, supplies, facility or trade secret information of the employer was used and which was developed entirely on the employee’s own time, and (1) which does
not relate (a) directly to the business of the employer or (b) to the employer’s actual or demonstrably anticipated research or development, or (2) which does not result from any work performed by the employee for the employer.
Any provision which purports to apply to such an invention is to that extent against the public policy of this state and is to that extent void and unenforceable. 

Subd. 2.Effect of subdivision 1. 

No employer shall require a provision made void and unenforceable by subdivision 1 as a condition of employment or continuing employment. 

Subd. 3.Notice to employee. 

If an employment agreement entered into after August 1, 1977 contains a provision requiring the employee to assign or offer to assign any
of the employee’s rights in any invention to an employer, the employer must also, at the time the agreement is made, provide a written notification to the employee that the agreement does not apply to an invention for which no equipment,
supplies, facility or trade secret information of the employer was used and which was developed entirely on the employee’s own time, and (1) which does not relate (a) directly to the business of the employer or (b) to the
employer’s actual or demonstrably anticipated research or development, or (2) which does not result from any work performed by the employee for the employer. 

I acknowledge receiving a copy of this Invention Assignment Notice: 
  

					
	 /s/ Steve Healy

Steve Healy
	 		  	 12-17-18

Date

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]